![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 14, 9901-9904, April 7, 2000
1*
**,
**,
**,
**,
¶, and
**
From the We used cloning in silico coupled
with polymerase chain reaction to demonstrate that IHG-2 is
part of the 3'-untranslated region of gremlin, a member of
the DAN family of secreted proteins that antagonize the bioactivities
of members of the transforming growth factor (TGF)-
Conway Institute of Biomolecular and
Biomedical Research, ** Centre for Molecular Inflammation and
Vascular Research, Department of Medicine and Therapeutics, University
College Dublin, Mater Misericordiae Hospital, Dublin 7, Ireland, the
§ Renal Division, Brigham and Women's Hospital, Harvard
Medical School, Boston, Massachusetts 02115, and the ¶ Department
of Pharmacology, University College Dublin, Belfield,
Dublin 4, Ireland
superfamily.
Mesangial cell gremlin mRNA levels were induced by high
glucose, cyclic mechanical strain, and TGF-
1 in vitro,
and gremlin mRNA levels were elevated in the renal
cortex of rats with streptozotocin-induced diabetic nephropathy
in vivo. gremlin expression was observed in
parallel with induction of bone morphogenetic
protein-2 (BMP-2), a target for gremlin in
models of cell differentiation. Together these data indicate that
(a) IHG-2 is gremlin,
(b) gremlin is expressed in diabetic
nephropathy in vivo, (c) both glycemic and
mechanical strain stimulate mesangial cell gremlin
expression in vitro, (d) high glucose induces
gremlin, in part, through TGF
-mediated pathways, and
(e) Gremlin is a potential endogenous antagonist of BMPs
within a diabetic glomerular milieu.
To whom correspondence should be addressed: Dept. of Medicine
and Therapeutics, Mater Misericordiae Hospital, University College Dublin, 41 Eccles St., Dublin 7, Ireland. Tel.: 353-1-803 7419; Fax:
353-1-830 8404; E-mail: hrbrady@mater.ie.
This article has been cited by other articles:
![]() |
M. Myllarniemi, P. Lindholm, M. J. Ryynanen, C. R. Kliment, K. Salmenkivi, J. Keski-Oja, V. L. Kinnula, T. D. Oury, and K. Koli Gremlin-mediated Decrease in Bone Morphogenetic Protein Signaling Promotes Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 321 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lee, S. J. O'Meara, C. O'Brien, and R. Kane The Role of Gremlin, a BMP Antagonist, and Epithelial-to-Mesenchymal Transition in Proliferative Vitreoretinopathy Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4291 - 4299. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mezzano, A. Droguett, M. Eugenia Burgos, C. Aros, L. Ardiles, C. Flores, D. Carpio, G. Carvajal, M. Ruiz-Ortega, and J. Egido Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1882 - 1890. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Russo, E. del Re, D. Brown, and H. Y. Lin Evidence for a Role of Transforming Growth Factor (TGF)-{beta}1 in the Induction of Postglomerular Albuminuria in Diabetic Nephropathy: Amelioration by Soluble TGF-{beta} Type II Receptor Diabetes, February 1, 2007; 56(2): 380 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pache, C. Schafer, S. Wiesemann, E. Springer, M. Liebau, H. C. Reinhardt, C. August, H. Pavenstadt, and M. J. Bek Upregulation of Id-1 via BMP-2 receptors induces reactive oxygen species in podocytes Am J Physiol Renal Physiol, September 1, 2006; 291(3): F654 - F662. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Koli, M. Myllarniemi, K. Vuorinen, K. Salmenkivi, M. J. Ryynanen, V. L. Kinnula, and J. Keski-Oja Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary Fibrosis Am. J. Pathol., July 1, 2006; 169(1): 61 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Shao, J. Cai, and D. A. Towler Molecular Mechanisms of Vascular Calcification: Lessons Learned From The Aorta Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1423 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Kane, L Stevenson, C Godson, A W Stitt, and C O'Brien Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose Br. J. Ophthalmol., December 1, 2005; 89(12): 1638 - 1642. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Haudenschild, S. M. Palmer, T. A. Moseley, Z. You, and A. H. Reddi Bone Morphogenetic Protein (BMP)-6 Signaling and BMP Antagonist Noggin in Prostate Cancer Cancer Res., November 15, 2004; 64(22): 8276 - 8284. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Koli, F. Wempe, A. Sterner-Kock, A. Kantola, M. Komor, W.-K. Hofmann, H. von Melchner, and J. Keski-Oja Disruption of LTBP-4 function reduces TGF-{beta} activation and enhances BMP-4 signaling in the lung J. Cell Biol., October 11, 2004; 167(1): 123 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vattikuti and D. A. Towler Osteogenic regulation of vascular calcification: an early perspective Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E686 - E696. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Avsian-Kretchmer and A. J. W. Hsueh Comparative Genomic Analysis of the Eight-Membered Ring Cystine Knot-Containing Bone Morphogenetic Protein Antagonists Mol. Endocrinol., January 1, 2004; 18(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Shao, S.-L. Cheng, N. Charlton-Kachigian, A. P. Loewy, and D. A. Towler Teriparatide (Human Parathyroid Hormone (1-34)) Inhibits Osteogenic Vascular Calcification in Diabetic Low Density Lipoprotein Receptor-deficient Mice J. Biol. Chem., December 12, 2003; 278(50): 50195 - 50202. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Connolly, D. Sadlier, N. E. Kieran, P. Doran, and H. R. Brady Transcriptome Profiling and the Pathogenesis of Diabetic Complications J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S279 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Canalis, A. N. Economides, and E. Gazzerro Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton Endocr. Rev., April 1, 2003; 24(2): 218 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Clarkson, M. Murphy, S. Gupta, T. Lambe, H. S. Mackenzie, C. Godson, F. Martin, and H. R. Brady High Glucose-altered Gene Expression in Mesangial Cells. ACTIN-REGULATORY PROTEIN GENE EXPRESSION IS TRIGGERED BY OXIDATIVE STRESS AND CYTOSKELETAL DISASSEMBLY J. Biol. Chem., March 15, 2002; 277(12): 9707 - 9712. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-N. WANG, J. LAPAGE, and R. HIRSCHBERG Loss of Tubular Bone Morphogenetic Protein--7 in Diabetic Nephropathy J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2392 - 2399. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |